IP Library Granted Patent US 6,844,335
Granted Patent B2
US 6,844,335 · App. 10/221,598 · Granted Jan 18, 2005

2-amino-3-(alkyl)-pyrimidone derivatives as GSK3.β.inhibitors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,844,335
App. No.
10/221,598
Granted
Jan 18, 2005
Kind
B2
Abstract

A pyrimidone derivative represented by formula (I) or a salt thereof: Wherein: R1 represents a hydrogen atom or a C 1-6 alkyl group which may be substituted by a C 6,10 aryl group; R2 represents a C 1-10 alkyl group which may be substituted, a C 2-6 alkenyl group which may be substituted, a C 3-6 alkynyl group which may be substituted, a C 3-6 cycloalkyl group which may be substituted, or a C 6-10 ARYL group which may be substituted; or R1 and R2 form together a C 2-6 alkylene group which may be substituted; or R1 and R2 form together a chain of formula —(CH 2 ) 2 —X—(CH 2 ) 2 — or —(CH 2 ) 2 —X—(CH 2 ) 3 — where X represents a oxygen atom, a sulfur atom, or a nitrogen atom which may be substituted; R3 represents a 2, 3 or 4-pyridyl group optionally substituted by a C 1-4 alkyl group, C 1-4 alkoxy group or halogen atom; and R4 represents a C 1-10 alkyl group optionally substituted by a hydroxyl group, amino, C 1-6 monoalkylamino group, C 2-12 dialkylamino group or C 6,10 aryl group which may be substituted. And a medicament comprising the said derivative or a salt thereof as an active ingredient which is used for preventive and/or therapeutic treatment of a neurodegenerative disease caused by abnormal activity of GSK3β such as Alzheimer's disease.

Claims (105)

1. A compound of formula (I):

wherein:

R1 and R2 together form a C 2-6 alklene group which may be substituted;

R3 represents a 2, 3 or 4-pyridyl group optionally substituted by a C 1-4 alkyl group, C 1-4 alkoxy group or a halogen atom; and

R4 represents a C 1-10 alkyl group optionally substituted by a hydroxyl, amino, C 1-6 monoalkylamino, C 2-12 dialkylamino, or C 6-10 aryl group which may be substituted; or a salt, solvate or hydrate thereof.

2. A compound selected from the group consisting of:

2-[[2-(phenyl)ethyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H )-one,

2-[[2-(4-methoxyphenyl)ethyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[2-(3methoxyphenyl)ethyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[2-(2-methoxyphenyl)ethyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[2-(2-fluorophenyl)ethyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[2-(3-fluorophenyl)ethyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[2-(4-fluorophenyl)ethyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[2-(4-bromophenyl)ethyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[2-(2-chlorophenyl)ethyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[2-(2,4-dichlorophenyl)ethyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[2-(4-aminophenyl)ethyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[2-(3,4-dimethoxyphenyl)ethyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[2-(2,5-dimethoxyphenyl)ethyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[2-(4-chlorophenyl)ethyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[2-(4-hydroxyphenyl)ethyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[2-(4-methylphenyl)ethyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[2-(4-aminosulfonylphenyl)ethyl]amino]-3-methyl -6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[2-(3-chlorophenyl)ethyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[2-(thiophen-2-yl)ethyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[4-(phenyl)butyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[2-(4-phenylmethoxyphenyl)ethyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[2-(4-phenylphenyl)ethyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[(phenylmethyl)amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[(2-methoxyphenyl)methyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[2-(2,5-dimethoxyphenyl)ethyl]methylamino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[[3-(3-aminopropoxy)phenyl]methyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[[3-(aminomethyl)phenyl]methyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[3-(phenyl)propyl]amino]-3-phenylmethyl-6-pyridin-4-ylpyrimidin4(3H)-one,

2-[[2-(1H-indol-3-yl)ethyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[2-(5-methoxy-1H-indol-3-yl)ethyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[2-(5-phenylmethoxy-1H-indol-3-yl)ethyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[2-(7-methyl-1 H -indol-3-yl)ethyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4-(3H)-one,

2-[[2-(1-methyl-1H-indol-3-yl)ethyl]amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[[2-(1-methyl-1H-indol-3-yl)ethyl]methylamino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-(cyclopentylamino)-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-(ethylamino)-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-[(indan-2-yl)amino]-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-(piperidin-1-yl)-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-(pyrrolidin-1-yl)-3-methyl-6-pyridin-4-ylpyrimidin-4(3H)-one,

2-(5-Amino-pentylamino)-3-methyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-(4-Amino-butylamino)-3-(3-phenyl-propyl)-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-(6-Amino-hexylamino)-3-(3-phenyl-propyl)-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-(5-Amino-pentylamino)-3-phenylethyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-(6-Amino-hexylamino)-3-phenethyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-(4-Amino-butylamino)-3-phenethyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-Cyclohexylamino-3-methyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-Butylamino-3-methyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

3-Methyl-2-pentylamino-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-Hexylamino-3-methyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-Heptylamino-3-methyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

3-Methyl-2-octylamino-6-pyridin-4-yl-3H-pyrimidin-4-one,

3-Methyl-2-nonylamino-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-Decylamino-3-methyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-(2-Cyclohexyl-ethylamino)-3-methyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

3-Methyl-2-(3-methyl-butylamino)-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-(Cyclohexylmethyl-amino)-3-methyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

3-Methyl-2-(2-propoxy-ethylamino)-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-(3-Cyclohexyl-propylamino)-3-methyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-(3-Ethoxy-propylamino)-3-methyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-[(5-Amino-pentyl)-phenetyl-amino]-3-methyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-(5-Hydroxy-pentylamino)-3-methyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-(4-Hydroxy-butylamino)-3-methyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-(3-Isopropoxy-propylamino)-3-methyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

3-Methyl-2-(3-propoxy-propylamino)-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-(2-Hydroxy-2-phenyl-ethylamino)-3-methyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-(2-Cyclopentyl-ethylamino)-3-methyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

3-Methyl-2-(3-piperidin-1-yl-propylamino)-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-[(3-Cyclohexyl-propyl)-methyl-amino]-3-methyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

Acetic acid 2-(1-methyl-6-oxo-4-pyridin-4-yl-1,6-dihydro-pyrimidin-2-ylamino)-1-phenyl-ethyl ester

2-(2-Adamantan-1-yl-ethylamino)-3-methyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-[3-(3-Hydroxy-propoxy)-benzylamino]-3-methyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

3-methyl-2-[3-(2-piperidin-4-yl-ethoxy)-benzylamino]-6-pyridin-4-yl-3H-pyrimidin-4-one,

Acetic acid 3-{3-[(1-methyl-6-oxo-4-pyridin-4-yl-1,6-dihydro-pyrimidin-2-ylamino)-methyl]-phenoxy}-propyl ester

2-[3-(3-Dimethylamino-propoxy)-benzylamino]-3-methyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

3-Methyl-2-{methyl-[2-(4-methylaminomethyl-phenyl)-ethyl]-amino}-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-[(4-Amino-butyl)-phenethyl-amino]-3-methyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-(3-Amino-propyl)-(3-phenyl-propyl)-amino)-6-pyridin-4-yl-3H-pyrimidin-4-one,

3-Methyl-2-(3-phenyl-propylamino)-6-pyridin-4-yl-3H-pyrimidin-4-one,

3-(5-Amino-pentyl)-2-(3-phenyl-propylamino)-6-pyridin-4-yl-3H-pyrimidin-4-one,

3-(4-Amino-butyl)-2-(3-phenyl-propylamino)-6-pyridin-4-yl-3H-pyrimidin-4-one,

3-Methyl-6-pyridin-4-yl-2-[3-(3-pyridin-4-yl-propoxy)-benzylamino]-3H-pyrimidin-4-one,

3-(6-Amino-hexyl)-2-(3-phenyl-propylamino)-6-pyridin-4-yl-3H-pyrimidin-4-one,

3-(6-Amino-hexyl)-2-phenethylamino-6-pyridin-4-yl-3H-pyrimidin-4-one,

3-(2-Amino-ethyl)-2-(3-phenyl-propylamino)-6-pyridin-4-yl-3H-pyrimidin-4-one,

3-(3-Amino-propyl)-2-[2-(2-methoxy-phenyl)-ethylamino]-6-pyridin-4-yl-3H-pyrimidin-4-one,

3-(2-Hydroxy-ethyl)-2-(3-phenyl-propylamino)-6-pyridin-4-yl-3H-pyrimidin-4-one,

3-(2-Dimethylamino-ethyl)-2-(3-phenyl-propylamino)-6-pyridin-4-yl-3H-pyrimidin-4-one,

3-(5-Amino-pentyl)-2-phenethylamino-6-pyridin-4-yl-3H-pyrimidin-4-one,

3-(4-Amino-butyl)-2-phenethylamino-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-(4-Amino-butylamino)-3-benzyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

2-(6-Amino-hexylamino)-3-benzyl-6-pyridin-4-yl-3H-pyrimidin-4-one,

3-Methyl-2-(2-phenylsulfanyl-ethylamino)-6-pyridin-4-yl-3H-pyrimidin-4-one,

3-Methyl-2-(2-phenylamino-ethylamino)-6-pyridin-4-yl-3H-pyrimidin-4-one,

3-Methyl-2-(2-phenoxy-ethylamino)-6-pyridin-4-yl-3H-pyrimidin-4-one,

3-Methyl-2-(3-phenyl-allylamino)-6-pyridin-4-yl-3H-pyrimidin-4-one,

3-Methyl-2-(3-phenyl-propylamino)-6-pyridin-4-yl-3H-pyrimidin-4-one, and

3-Methyl-6-pyridin-4-yl-2(2-pyridin-2-yl-ethylamino)-3H-pyrimidin-4-one or a salt thereof, or a solvate thereof or a hydrate thereof.

3. A pharmaceutical composition comprising a compound according to claim 1 together with a pharmaceutically acceptable excipient.

4. A pharmaceutical composition comprising a compound according to claim 2 together with a pharmaceutically acceptable excipient.

Assignments (3)
CHANGE OF NAME Recorded Jun 20, 2012
From: SANOFI-AVENTIS
To: SANOFI
Reel/Frame 028413/0927 →
CHANGE OF NAME Recorded Jul 22, 2005
From: SANOFI-SYNTHELABO
To: SANOFI-AVENTIS
Reel/Frame 016345/0189 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2002
From: ALMARIO GARCIA, ANTONIO; ANDO, RYOICHI; ARITOMO, KEIICHI; FROST, JONATHAN REID; LI, ADRIEN TAK; SHODA, AYA; UEHARA, FUMIAKI; WATANABE, KAZUTOSHI
To: SANOFI-SYNTHELABO; MITSUBISHI PHARMA CORPORATION
Reel/Frame 013549/0858 →